BR9714631A - Método para tratar terapeuticamente olhos de mamìferos e medicamento antiinfeccioso de iodo não-irritante, oftálmico - Google Patents

Método para tratar terapeuticamente olhos de mamìferos e medicamento antiinfeccioso de iodo não-irritante, oftálmico

Info

Publication number
BR9714631A
BR9714631A BR9714631-5A BR9714631A BR9714631A BR 9714631 A BR9714631 A BR 9714631A BR 9714631 A BR9714631 A BR 9714631A BR 9714631 A BR9714631 A BR 9714631A
Authority
BR
Brazil
Prior art keywords
iodine
ophthalmic
irritating
mammalian eyes
therapeutically treating
Prior art date
Application number
BR9714631-5A
Other languages
English (en)
Inventor
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of BR9714631A publication Critical patent/BR9714631A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<B>MéTODO PARA TRATAR TERAPEUTICAMENTE OLHOS DE MAMìFEROS E MEDIAMENTO ANTIINFECCIOSO DE IODO NãO-IRRITANTE, OFTáLMICO<D>. A presente invenção refere-se a um microbicida de iodo gerado enzimaticamente para a inativação de organismos patogênicos contaminantes em ou em materiais biologicos sensíveis tais como o olho humano. O agente biocida da reação enzimática é iodo molecular livre gerado em um nível mínimo de 5 ppm e compreende pelo menos 25% de espécie de iodo total presente em uma base molar.
BR9714631-5A 1997-03-24 1997-05-31 Método para tratar terapeuticamente olhos de mamìferos e medicamento antiinfeccioso de iodo não-irritante, oftálmico BR9714631A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/826,068 US5849291A (en) 1994-10-17 1997-03-24 Opthalmic non-irritating iodine medicament
PCT/US1997/009110 WO1998042313A1 (en) 1997-03-24 1997-05-31 Opthalmic non-irritating iodine medicament and method

Publications (1)

Publication Number Publication Date
BR9714631A true BR9714631A (pt) 2000-03-28

Family

ID=25245616

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9714631-5A BR9714631A (pt) 1997-03-24 1997-05-31 Método para tratar terapeuticamente olhos de mamìferos e medicamento antiinfeccioso de iodo não-irritante, oftálmico

Country Status (8)

Country Link
US (1) US5849291A (pt)
EP (1) EP0969814A1 (pt)
JP (1) JP2001526647A (pt)
CN (1) CN1248911A (pt)
AU (1) AU725930C (pt)
BR (1) BR9714631A (pt)
CA (1) CA2284696A1 (pt)
WO (1) WO1998042313A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482309B1 (en) 1999-10-20 2002-11-19 Oxibio, Inc. Electrolytic generation of nascent iodine as a method of treatment and for the prevention of infections associated with medical implant devices
WO2001047534A1 (en) * 1999-12-28 2001-07-05 Symbollon Corporation Non-staining topical iodine composition
ATE405265T1 (de) * 2000-11-08 2008-09-15 Fxs Ventures Llc Verbesserte ophthalmologische und kontaktlinsenlösungen mit vitamin-b-formen
US20030118472A1 (en) * 2001-08-08 2003-06-26 Mckee Mary Mowrey Disinfecting and cleaning system for contact lenses
PL1808170T3 (pl) 2004-11-05 2011-12-30 Senju Pharma Co Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
CA2784492C (en) * 2009-12-15 2020-06-30 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP2510944A1 (en) * 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
GB201114725D0 (en) 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
EP4420725A2 (en) 2012-03-29 2024-08-28 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
ES2974663T3 (es) 2012-09-12 2024-07-01 Novaliq Gmbh Alcanos semifluorados para uso en la solubilización de meibomio
CA2883003C (en) 2012-09-12 2021-11-16 Novaliq Gmbh Semifluorinated alkane compositions
EP2799068A1 (en) * 2013-05-01 2014-11-05 National University of Ireland, Galway Antimicrobial compositions and methods for their production
KR102697203B1 (ko) 2016-07-21 2024-08-22 아이2퓨어 코프. 연화성 국소 소독제
EP3612228B1 (en) 2017-04-21 2023-08-23 Dermaliq Therapeutics, Inc. Iodine compositions
JP7500550B2 (ja) 2018-10-12 2024-06-17 ノバリック ゲーエムベーハー 乾性眼疾患の治療のための眼科用組成物
CN110559175A (zh) * 2019-08-27 2019-12-13 陈文龙 一种结膜囊消毒溶液及其使用方法和装置
US20230181625A1 (en) * 2021-12-14 2023-06-15 Harrow Ip, Llc Method and composition for treating infectious conjunctivitis
EP4309500A1 (en) * 2022-07-18 2024-01-24 Acies Bio d.o.o. Peroxidase based biocontrol agents
WO2024017883A1 (en) * 2022-07-18 2024-01-25 Acies Bio D.O.O. Peroxidase based biocontrol agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588586A (en) * 1983-01-03 1986-05-13 Kessler Jack H Method for disinfecting a contact lens
US4996146A (en) * 1987-02-20 1991-02-26 Kessler Jack H Rapid sterilization enzymatic process with persistence
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
US5227161A (en) * 1988-09-06 1993-07-13 Symbollon Corporation Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, iodide compound and surfactant
DE69027424T2 (de) * 1990-03-20 1997-02-20 Symbollon Corp Verfahren und Zusammensetzung zur Kontrolle der Farbe in einem desinfizierenden Peroxyd-Peroxydase-System
US5419902A (en) * 1993-07-16 1995-05-30 Symbollon Corporation Method for inactivating pathogens
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition
US5648075A (en) * 1994-10-17 1997-07-15 Symbollon Corporation Iodine based germicidal composition
US5639481A (en) * 1994-10-17 1997-06-17 Symbollon Corporation Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine

Also Published As

Publication number Publication date
AU3288697A (en) 1998-10-20
EP0969814A1 (en) 2000-01-12
US5849291A (en) 1998-12-15
AU725930C (en) 2001-09-06
CA2284696A1 (en) 1998-10-01
AU725930B2 (en) 2000-10-26
WO1998042313A1 (en) 1998-10-01
JP2001526647A (ja) 2001-12-18
CN1248911A (zh) 2000-03-29

Similar Documents

Publication Publication Date Title
BR9714631A (pt) Método para tratar terapeuticamente olhos de mamìferos e medicamento antiinfeccioso de iodo não-irritante, oftálmico
BRPI0414331A (pt) método de destruição de bactéria numa área de tratamento do paciente e composição antimicrobiana de terapia fotodinámica
PT710124E (pt) Metodo de esterilizacao de produtos
ATE128004T1 (de) Polymere quaternäre ammoniumtrihalogenide, nützlich als mikrobizide, sterilisations- und desinfektionsmittel.
DK62286D0 (da) Ikke-antibakterielle tetracyclinpraeparater med anticollagenolytiske egenskaber
DE69409285D1 (de) System zur Laserbehandlung von Brechungsfehlern des Auges
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
ATE247487T1 (de) Stable komplexen von vernetzten polyvinylpyrrolidone und iod und verfahren zur herstellung
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
WO1997003188A3 (de) Verwendung von mp52 oder mp121 zur behandlung und prävention von erkrankungen des nervensystems
DE69825128D1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ATE158687T1 (de) Fungizide mittel zur verhinderung des wachstums des schimmels bei lebensmitteln und landwirtschaftlichen produkten
KR950010898A (ko) 재조합 사람 혈청 알부민 약제학적 제제의 멸균법
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
NO179472C (no) Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
DE69034147D1 (de) Verfahren zur Desinfektion von Knochengeweben
ATE193450T1 (de) Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
DE69928814D1 (de) Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten
RU96104662A (ru) Штамм бактерий bacillus subtilis, используемый для обеззараживания птичьего помета и навоза от патогенных микроорганизмов
DE69411833D1 (de) Verwendung von Chinonen zur Herstellung eines Arzneimittels zur Vorbeugung und Behandlung von allergischer Rhinitis
ATE206617T1 (de) Verwendung von escherichia coli stamm dsm 6601 zur behandlung von diarrhoeen auf dem veterinärsektor
DE3761283D1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1836 DE 14/03/2006.